Effects of Empagliflozin on Sarcopenia Risk, Body Composition, and Muscle Strength in Type 2 Diabetes: A 24-Week Real-World Observational Study.

Empagliflozin 對第二型糖尿病患者肌少症風險、身體組成及肌力的影響：24週真實世界觀察性研究